Literature DB >> 22447882

Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis.

Benjamin Wilde1, Fan Hua, Sebastian Dolff, Cao Jun, Xin Cai, Christof Specker, Thorsten Feldkamp, Andreas Kribben, Jan Willem Cohen Tervaert, Oliver Witzke.   

Abstract

OBJECTIVE: Persistent T-cell activation is frequently observed in granulomatosis with polyangiitis (GPA, formerly known as Wegener's granulomatosis). T-cell activation is usually balanced by negative costimulatory molecules. The negative costimulator programmed death receptor-1 (PD-1) and its relevance to T-cell immunity have not been studied so far in GPA. Thus it is the aim of the study to characterize the role of PD-1 in GPA.
METHODS: Thirty-two patients suffering from GPA and 19 age-matched healthy controls (HCs) were enrolled. T-lymphocyte subsets from peripheral blood were analysed by flow cytometry for the expression of PD-1. The frequency of memory T cells and T cells producing pro-inflammatory cytokines was determined. Renal biopsies from GPA patients were stained for CD3 and PD-1.
RESULTS: PD-1 expression was increased on T-helper cells (Th cells) from GPA patients as compared with HCs. In addition, parameters of persistent T-cell activation and production of pro-inflammatory cytokines were positively associated with numbers of PD-1(+) Th cells in patients but not in HCs. Latent infection with CMV seemed to enhance PD-1 expression on CD4(+) and CD4(+)CD25(-) T cells. Interestingly, expression of PD-1 on CD4(+)CD25(+)T cells was inversely correlated with relapse rate. Importantly, lesional T cells were mostly lacking PD-1.
CONCLUSIONS: The expression of the negative costimulator PD-1 is altered in GPA and might counterbalance persistent T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447882     DOI: 10.1093/rheumatology/kes034

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  20 in total

Review 1.  Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis.

Authors:  Mohammed S Osman; Jan Willem Cohen Tervaert
Journal:  Curr Rheumatol Rep       Date:  2019-12-26       Impact factor: 4.592

2.  Reply: To PMID 23553415.

Authors:  Meghan E Free; Maureen A Su
Journal:  Arthritis Rheum       Date:  2013-12

Review 3.  Checkpoint Molecules in Rheumatology-or the Benefits of Being Exhausted.

Authors:  Stinne Ravn Greisen; Bent Deleuran
Journal:  Curr Rheumatol Rep       Date:  2021-03-02       Impact factor: 4.592

4.  Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Authors:  Christopher S Nabel; Mariano Severgnini; Yin P Hung; Amy Cunningham-Bussel; Evisa Gjini; Katja Kleinsteuber; Lake J Seymour; Martha K Holland; Rachel Cunningham; Kristin D Felt; Marina Vivero; Scott J Rodig; Elena M Massarotti; Osama E Rahma; Lauren C Harshman
Journal:  Oncologist       Date:  2019-05-14

5.  Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.

Authors:  Hui Zhang; Ryu Watanabe; Gerald J Berry; Augusto Vaglio; Yaping Joyce Liao; Kenneth J Warrington; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

Review 6.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 7.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

Review 8.  Checks and Balances in Autoimmune Vasculitis.

Authors:  Rebeca Hid Cadena; Wayel H Abdulahad; G A P Hospers; T T Wind; Annemieke M H Boots; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

9.  Abnormal expression pattern of the IL-2 receptor β-chain on CD4+ T cells in ANCA-associated vasculitis.

Authors:  Benjamin Wilde; André Hoerning; Andreas Kribben; Oliver Witzke; Sebastian Dolff
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

10.  Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls.

Authors:  B Wilde; A Mertens; S J Arends; R P Rouhl; R Bijleveld; J Huitema; S A Timmermans; J Damoiseaux; O Witzke; A M Duijvestijn; P van Paassen; R J van Oostenbrugge; J W Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2016-06-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.